Consistent with this idea, patients with basal-like BCs (ER− or low expression) are more likely to be obese, compared with underweight/normal patients [26], and tumors with high AR and low ER expression levels (AR/ER ratio ≥2) are associated with more aggressive BC molecular subtypes [90,136]. Here, AR is linked to breast cancer.